{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:49:39Z","timestamp":1782226179147,"version":"3.54.5"},"reference-count":20,"publisher":"Galenos Yayinevi","issue":"3","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Turk Gogus Kalp Dama"],"accepted":{"date-parts":[[2022,1,24]]},"published-print":{"date-parts":[[2022,7,1]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    This study aims to investigate the relationship between preoperative erythrocyte sedimentation rate and survival in patients undergoing pulmonary resection due to lung cancer.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    Between January 2011 and July 2017, a total of 575 patients (433 males, 142 females; mean age: 61.2\u00b19.9 years; range, 29 to 82 years) who were operated due to primary lung cancer in our clinic were retrospectively analyzed. The patients were grouped according to erythrocyte sedimentation rate to analyze the relationship between erythrocyte sedimentation rate and survival.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    The mean overall survival time was 61.8\u00b11.7 months in 393 patients with an erythrocyte sedimentation rate of \u226424 mm\/h and 48.9\u00b12.9 months in 182 patients with an erythrocyte sedimentation rate of \u226525 mm\/h (p&lt;0.001). Among the patients with Stage 1-2 disease, the mean survival time was 66.2\u00b11.9 in patients with an erythrocyte sedimentation rate of \u226424 mm\/h and 53.8\u00b13.2 in patients with an erythrocyte sedimentation rate of \u226525 mm\/h (p=0.008). The mean survival time in patients with adenocarcinoma was 62.4\u00b12.4 months in patients with \u226424 mm\/h erythrocyte sedimentation rate and 46.1\u00b14.6 months in patients with \u226525 mm\/h erythrocyte sedimentation rate (p=0.003).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    The relationship between elevated erythrocyte sedimentation rate and poor prognosis in patients with the same stage of the disease is promising for the use of erythrocyte sedimentation rate as a prognostic marker.\n                  <\/jats:p>","DOI":"10.5606\/tgkdc.dergisi.2022.21217","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T04:57:59Z","timestamp":1660193879000},"page":"381-388","source":"Crossref","is-referenced-by-count":7,"title":["Relationship between survival and erythrocyte sedimentation rate in patients operated for lung cancer"],"prefix":"10.4274","volume":"30","author":[{"given":"Ahmet","family":"Kayahan Tekneci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tevfik","family":"\u0130lker Ak\u00e7am","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6nder","family":"Kavurmac\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"G\u00fcl Erg\u00f6n\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"\u00d6zdil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kutsal","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpaslan","family":"\u00c7akan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"\u00c7a\u011f\u0131r\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","reference":[{"key":"ref-1","doi-asserted-by":"crossref","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.","DOI":"10.1002\/ijc.29210"},{"key":"ref-2","unstructured":"American Cancer Society. Cancer Facts & Figures 2013. In. Atlanta, GA: American Cancer Society; 2013."},{"key":"ref-3","doi-asserted-by":"crossref","unstructured":"Wang BY, Huang JY, Cheng CY, Lin CH, Ko J, Liaw YP. Lung cancer and prognosis in taiwan: A population-based cancer registry. J Thorac Oncol 2013;8:1128-35.","DOI":"10.1097\/JTO.0b013e31829ceba4"},{"key":"ref-4","doi-asserted-by":"crossref","unstructured":"Paesmans M. Prognostic and predictive factors for lung cancer. Breathe 2012;9:112-21.","DOI":"10.1183\/20734735.006911"},{"key":"ref-5","doi-asserted-by":"crossref","unstructured":"Zimmermann FB. Prognostic Factors in Lung Cancer. In: Jeremi? B, editor. Advances in Radiation Oncology in Lung Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg; 2005. p. 411-20.","DOI":"10.1007\/3-540-26632-1_32"},{"key":"ref-6","doi-asserted-by":"crossref","unstructured":"Aoe K, Hiraki A, Ueoka H, Kiura K, Tabata M, Tanaka M, et al. Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration 2004;71:170-3.","DOI":"10.1159\/000076679"},{"key":"ref-7","doi-asserted-by":"crossref","unstructured":"Yin Y, Wang J, Wang X, Gu L, Pei H, Kuai S, et al. Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis. Clinics (Sao Paulo) 2015;70:524-30.","DOI":"10.6061\/clinics\/2015(07)10"},{"key":"ref-8","doi-asserted-by":"crossref","unstructured":"Saadeh C. The erythrocyte sedimentation rate: Old and new clinical applications. South Med J 1998;91:220-5.","DOI":"10.1097\/00007611-199803000-00001"},{"key":"ref-9","unstructured":"Smith EM, Samadian S. Use of the erythrocyte sedimentation rate in the elderly. Br J Hosp Med 1994;51:394-7."},{"key":"ref-10","doi-asserted-by":"crossref","unstructured":"Sox HC Jr, Liang MH. The erythrocyte sedimentation rate. Guidelines for rational use. Ann Intern Med 1986;104:515-23.","DOI":"10.7326\/0003-4819-104-4-515"},{"key":"ref-11","doi-asserted-by":"crossref","unstructured":"Johansson JE, Sigurdsson T, Holmberg L, Bergstr\u00f6m R. Erythrocyte sedimentation rate as a tumor marker in human prostatic cancer. An analysis of prognostic factors in 300 population-based consecutive cases. Cancer 1992;70:1556-63.","DOI":"10.1002\/1097-0142(19920915)70:6<1556::AID-CNCR2820700619>3.0.CO;2-I"},{"key":"ref-12","doi-asserted-by":"crossref","unstructured":"Yayan J. Erythrocyte sedimentation rate as a marker for coronary heart disease. Vasc Health Risk Manag 2012;8:219-23.","DOI":"10.2147\/VHRM.S29284"},{"key":"ref-13","doi-asserted-by":"crossref","unstructured":"Tas F, Erturk K. Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma. Mol Clin Oncol 2017;7:1142-6.","DOI":"10.3892\/mco.2017.1440"},{"key":"ref-14","unstructured":"Eboreime O, Atoe K, Idemudia JO. Erythrocyte sedimentation rate and C-reactive protein levels in breast cancer patients in Benin City, Nigeria. IOSR Journal of Dental and Medical Sciences 2015;14:116-9."},{"key":"ref-15","doi-asserted-by":"crossref","unstructured":"Hou X, Jiang L, Chen C, Zhu X, Ge M. Different expression of erythrocyte sedimentation rate and C-reactive protein in papillary thyroid carcinoma and nodular goiter. Clin Lab 2015;61:793-9.","DOI":"10.7754\/Clin.Lab.2015.150127"},{"key":"ref-16","unstructured":"Zhang YH, Guo LJ, Kuang TG, Zhu M, Liang LR. Association between the erythrocyte sedimentation rate, serum C-reactive protein and risk of lung cancer. Zhonghua Zhong Liu Za Zhi 2010;32:48-51."},{"key":"ref-17","doi-asserted-by":"crossref","unstructured":"Yue D, Gong L, You J, Su Y, Zhang Z, Zhang Z, et al. Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines. BMC Cancer 2014;14:422.","DOI":"10.1186\/1471-2407-14-422"},{"key":"ref-18","unstructured":"Crosbie PA, Shah R, Summers Y, Dive C, Blackhall F. Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum\/plasma markers. Transl Lung Cancer Res 2013;2:382-97."},{"key":"ref-19","doi-asserted-by":"crossref","unstructured":"Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-14.","DOI":"10.1097\/JTO.0b013e31812f3c1a"},{"key":"ref-20","doi-asserted-by":"crossref","unstructured":"\u015eahin M, Yenig\u00fcn MB, Kocaman G, Duman E, Sakall\u0131 MA, \u00d6zkan M, et al. Sublobar resections in early-stage non-small cell lung cancer. Turk Gogus Kalp Dama 2019;27:367-73.","DOI":"10.5606\/tgkdc.dergisi.2019.17695"}],"container-title":["Turkish Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tgkdc.dergisi.org\/uploads\/pdf\/pdf_TGKDC_3571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/tgkdc.dergisi.org\/uploads\/pdf\/pdf_TGKDC_3571.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:51:55Z","timestamp":1782222715000},"score":1,"resource":{"primary":{"URL":"https:\/\/tjtcvs.org\/articles\/doi\/tgkdc.dergisi.2022.21217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.5606\/tgkdc.dergisi.2022.21217","relation":{},"ISSN":["1301-5680","2149-8156"],"issn-type":[{"value":"1301-5680","type":"print"},{"value":"2149-8156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}